Profound Medical Corp (PRN-T) Analyst Research & Price Targets - The Globe and Mail

Earnings Estimates

	Current Qtr06/2026	Next Qtr09/2026	Fiscal Yr12/2026	Fiscal Yr12/2027
Average Estimate	$-0.30	$-0.31	$-1.20	$-1.11
Number of Estimates	3	3	3	3
High Estimate	$-0.26	$-0.28	$-1.18	$-0.37
Low Estimate	$-0.33	$-0.34	$-1.24	$-2.02
Prior Year	$-0.72	$-0.36	$-1.97	$-1.20
Growth Rate Est. (year over year)	+58.33%	+13.89%	+39.09%	+7.50%

Earnings History - Surprises*

	Qtr Ending03/2026	Qtr Ending12/2025	Qtr Ending09/2025	Qtr Ending06/2025
Reported	$-0.26	$-0.38	$-0.36	$-0.72
Estimate	$-0.33	$-0.38	$-0.53	$-0.60
Difference	+0.07	unch	+0.17	-0.12
Surprise	+21.21%	unch	+32.08%	-20.00%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.75

3 Mths Ago4

4.75

2 Mths Ago4

4.75

1 Mth Ago4

4.75

Current4

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	4	4	4	4
	3 1	3 1	3 1	3 1
Holds	0	0	0	0

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

Thursday’s analyst upgrades and downgrades

Wednesday’s analyst upgrades and downgrades

number cruncher

Seven Canadian small-cap stocks with cheap valuations

Bullish on Freeport-McMoRan Inc.

Gildan shares sink 19 per cent on short seller report alleging inflated sales

The highest-yielding stocks on the TSX, plus risk data

The most oversold and overbought stocks on the TSX

Insider Report: Co-chair buys the dip investing over US$1-million in this beaten-down stock